Klug, Lillian R.
Bannon, Amber E.
Javidi-Sharifi, Nathalie
Town, Ajia
Fleming, William H.
VanSlyke, Judy K.
Musil, Linda S.
Fletcher, Jonathan A.
Tyner, Jeffrey W.
Heinrich, Michael C.
Article History
Received: 13 March 2018
Revised: 1 August 2018
Accepted: 29 August 2018
First Online: 21 September 2018
Compliance with ethical standards
:
: MCH is a consultant for Novartis, Deciphera Pharmaceuticals, Blueprint Medicines, Ariad Pharmaceuticals, Bayer Pharmaceuticals, and Molecular MD. MCH has provided expert testimony and has a patent licensed to Novartis. MCH receives research support from Ariad, Deciphera, Blueprint Medicines and has equity interest in Molecular MD. JWT receives research support from Agios Pharmaceuticals, Array Biopharma, Aptose Biosciences, AstraZeneca, Constellation Pharmaceuticals, Genentech, Gilead, Incyte Corporation, Janssen Pharmaceutica, Seattle Genetics, Syros, Takeda Pharmaceutical Company and is a consultant for Leap Oncology.